The Oncogenic Role of KLF7 in Colon Adenocarcinoma and Therapeutic Perspectives

Table 2

Cancer-specific survival analyses of COAD cohort from our hospital.

Variables	Cases ()	5-year CSS (%)	value
Sex
Female	84	73.4%	0.510
Male	91	76.4%
Age (years old)
≤65	72	84.0%	0.018
>65	103	69.4%
Tumor size (cm)
<5.0	109	79.9%	0.272
≥5.0	66	67.5%
Tumor location
Ascending colon	53	82.3%	0.087
Transverse colon	38	67.9%
Descending-sigmoid colon	84	75.2%
Differentiation grade
Grades I-II	144	75.3%	0.811
Grades III-IV	31	74.6%
T stage
T1	23	100%	<0.001
T2	42	84.2%
T3	86	78.3%
T4	24	19.9%
N stage
N0	104	82.8%	<0.001
N1	52	69.5%
N2	19	51.3%
Chemotherapy
No or unknown	118	78.0%	0.202
Yes	57	70.2%
KLF7 level
Low	87	90.2%	<0.001
High	88	58.7%